Company Number: 14485232

Analysis Date: 2025-07-20 17:55 UTC

1. Credit Opinion: APPROVE
   Clinical Data Services Ltd exhibits a solid micro-entity financial profile with positive net assets and no overdue filings, indicating sound compliance and financial stewardship. The company is newly incorporated (Nov 2022) but shows a healthy working capital position, suggesting capability to meet short-term obligations. The majority shareholder and director is also the sole controller, which simplifies management oversight but requires monitoring for governance risks. Overall, the company appears creditworthy for modest credit facilities, subject to standard conditions such as ongoing timely filing and maintenance of liquidity.

2. Financial Strength:

• Fixed assets are minimal (£1.7k), typical for a data processing business relying on intangible assets or low capital intensity.
• Current assets (£35.8k) far exceed current liabilities (£9.1k), producing net current assets (working capital) of £26.7k.
• Net assets stand at £28.4k, representing the shareholder funds and indicating no leverage or external debt.
• The balance sheet is clean, with no signs of accumulated losses or credit risk exposures.
• The micro-entity status limits detailed disclosure, but available data suggests a stable financial position with no immediate solvency concerns.

3. Cash Flow Assessment:

• The positive working capital and liquidity buffer imply the company can cover its short-term liabilities comfortably.
• Absence of debt means no interest charges or refinancing risk.
• Given the company's young age and limited employee base, cash flow volatility risk is moderate but manageable.
• Without a profit and loss statement, cash generation capacity cannot be fully assessed; however, the current asset composition likely includes cash or receivables supporting operational needs.
• Continued monitoring of cash flow from operations is recommended as the business scales.

4. Monitoring Points:

• Watch for timely filing of next accounts and confirmation statement to ensure compliance persistence.
• Monitor growth in current liabilities relative to current assets to avoid liquidity squeeze.
• Review any future borrowings or credit facility usage that may impact leverage and repayment capacity.
• Observe the business’s revenue trends and profitability once P&L data becomes available to validate operational cash flow strength.
• Governance oversight is concentrated in one director/shareholder; any changes in ownership or management should be noted.